Previous research in the Mackay region 7, [9] [10] [11] 15 and recent interviews (unpublished data) showed that most general practi tioners in Mackay use chlorhexidine in preference to povidone iodine, partly because of the perceived "messiness" and skin staining associated with povidone iodine. Therefore, in the cur rent study, we examined the difference between alcoholic and aqueous chlorhexidine, rather than comparing chlorhexidine with povidone iodine.
Alcoholic chlorhexidine has the potential for more pro nounced mucosal and ocular irritation 16 and the danger of oper ating room fires which, though rare, can have catastrophic con sequences. 17 Several participating clinicians commented that alcoholic chlorhexidine was more likely to remove skin markings made to establish excision margins (unpublished data). We hypothesized that alcoholic chlorhexidine, with independent antibacterial properties, would be superior to aqueous chlorhexi dine, and felt that it was important to establish whether a signifi cant difference in efficacy could justify the potential negative effects of the alcoholic preparation.
The aim of our study, the AVALANCHE (Aqueous Versus Alco holic Antisepsis with Chlorhexidine for Skin Excision) trial, was to compare the effect of alcoholic and aqueous chlorhexidine on the incidence of surgical site infection after minor skin excisions in general practice.
Methods

Study design and setting
We conducted this prospective, multicentre assessorblinded ran domized controlled trial (RCT) from October 2015 to August 2016, with reporting in accordance with the CONSORT statement. 18 We conducted the trial in 3 private general practices in Mackay, Queensland (population 112 798), 19 and 1 private gen eral practice in Mareeba, Queensland (population 7294).
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Intervention and control
For preoperative skin antisepsis, the intervention was 0.5% chlorhexidine in 70% ethanol, and the control was 0.5% chlorhexidine aqueous solution. The 0.5% concentration aligns with guidelines released by the Queensland Centre for Health care Related Infection Surveillance and Prevention. 4 The 70% alcoholic concentration is standard for alcoholic preoperative skin preparations. 2 We purchased the antiseptic solutions from an independent supplier (SSS Australia).
Recruitment and participant eligibility
Consecutive adult patients presenting for "minor skin excision" (i.e., excision of benign or malignant skin lesions under local anes thetic, performed in general practice) were invited to participate. Practice nurses were responsible for recruitment and treatment assignment. Nurses provided an information sheet to each poten tial participant before requesting written informed consent.
We excluded patients who were already taking antibiotics. Other exclusion criteria were excision of sebaceous cyst and allergy to alcohol or chlorhexidine. Additional methodologic details are outlined in the study protocol. 21 We did not plan to exclude periocular excisions; however, dur ing the first week of data collection, 1 patient experienced ocular irritation from an alcoholic solution, and patients with this type of lesion were excluded thereafter. We reported this event as an adverse reaction.
Randomization and blinding
Randomization was at the level of the patient. We used computergenerated random numbers to create permuted blocks of 50 with a 1:1 ratio. Group assignments were concealed in numbered, sealed, opaque envelopes, which were opened after patients provided consent to participate. The researchers responsible for randomization had no role in participant enrol ment, assignment or treatment.
Some features of the alcoholic preparation, such as smell, were identifiable, so blinding of personnel and patients was not feasible. However, the outcome assessor (the treating doctor) was blinded to treatment assignment. In addition, to improve the specificity (but not the sensitivity) of diagnosis of surgical site infection, a single blinded outcome assessor photographed and assessed infected wounds.
Surgical and wound care protocols
In consultation with the participating clinicians, we developed a protocol modelled upon international guidelines and similar trials. 4, 7, 9, 10, 15, 22 The antiseptic solution was applied using sterile forceps and gauze over an area 1 cm beyond the surgical field. Drapes, gloves, sutures, local anesthetic and dressings were the same in the 2 study arms. Written postoperative wound care instructions were used. In addition, the clinicians used a dia thermy protocol to minimize the risk of fires. 4, 17, 23 Surgical site infection was determined in accordance with a modified version of the Centers for Disease Control and Preven tion (CDC) definition. 22 The infection was required to occur within 30 days of the excision and to involve only skin or subcutaneous tissue. Additionally, at least 1 of the following had to have occurred: purulent discharge with or without laboratory confir mation from the superficial excision; at least 1 of pain or tender ness, localized swelling, redness or heat; or diagnosis of superfi cial infection by the physician. Stitch abscess was not included in this definition. 9, 15, 22 
Outcome measures
The primary outcome measure was the incidence of surgical site infection within 30 days after the excision. Wounds were assessed when the patients presented for removal of sutures, for evaluation of signs or symptoms of surgical site infection or for any other reason (opportunistically).
The secondary outcome measures were adverse reactions to the preoperative skin antiseptic agent (manifesting as any one of anaphylaxis, skin irritation, contact dermatitis or rash), the results of microbiology testing of infected wounds with purulent discharge and any patterns of antibiotic resistance. Ocular irrita tion was classified as an adverse reaction.
Participating clinicians were given standardized education about the diagnosis of surgical site infection. The clinicians pre scribed antibiotics for such infections if clinically indicated and, for wounds with a purulent discharge, obtained samples for microscopy, culture and sensitivity (as per standard practice).
Data collection
Staff at each practice location collected baseline data for patient, excision and lesion characteristics, based on risk factors for sur gical site infection identified in previous trials. [7] [8] [9] 15 Excision loca tion was recorded on a body site map. Clinicians at each practice site examined patient records to complete missing data.
Statistical analysis
For determination of sample size, we predicted a baseline infec tion rate of 10%, on the basis of pooled data from 3 previous studies of surgical site infection in the Mackay region, 7,9,10 which used aqueous chlorhexidine. We contacted participating clin icians individually to seek input on the level of reduction in the incidence of surgical site infection that would be considered clin ically significant; these clinicians judged that an absolute reduc tion in incidence of 5% (i.e., to 5%) with alcoholic chlorhexidine would be clinically significant. To detect a difference of this mag nitude with statistical confidence, power in excess of 80% and a 2tailed significance level of 0.05, a total of 435 patients was required in each of the intervention and control groups. To counter potential attrition, and given dropout rates less than 5% in previ ous studies, 7,9,10,15 the target sample size was increased to 920. We compared the intervention and control groups in terms of baseline characteristics of patients, lesions and excisions.
We compared the incidence of surgical site infection (the pri mary outcome variable) in the intervention and control groups using the Fisher exact test and 95% confidence intervals (CIs). In addition, we calculated the attributable risk reduction, the rela tive risk, the number needed to treat (NNT) and the number neeed to harm (NNH) 24 with 95% CIs. The primary analysis was an intentiontotreat analysis based on cases available at followup, including all participants who underwent randomization, with the individual person as the unit of analysis. We also conducted a per protocol analysis, which excluded participants with protocol violations, and a sensitivity analysis for patients lost to followup. In addition, we compared the relative incidence of adverse outcomes between the inter vention and control groups using the Fisher exact test. All reported p values were 2 tailed, and for each analysis p less than 0.05 was considered statistically significant.
Data were analyzed with SPSS Statistics version 24 (IBM).
Ethics approval
This trial received ethics approval from the James Cook Univer sity Human Research Ethics Committee (H6065) and was regis tered with the Australian and New Zealand Clinical Trials Registry (ACTRN12615001045505).
Results
Over the study period, 1041 patients were assessed for eligibility and met the inclusion criteria, of whom 125 were excluded ( Figure 1 ). At baseline, there were no large differences between the intervention and control groups in terms of patient, lesion or excision characteristics ( Table 1) .
Incidence of surgical site infection
In the intentiontotreat analysis of cases available at follow up, surgical site infection occurred in 57 (6.3%, 95% CI 4.7% to 7.9%) of the 909 patients. There was no significant difference between the alcoholic and aqueous chlorhexidine arms (5.8% [26/451] , 95% CI 3.6% to 7.9% v. 6.8% [31/458] , 95% CI 4.5% to 9.1%). The attributable risk reduction was 0.010 (95% CI -0.021 to 0.042), relative risk was 0.85 (95% CI 0.51 to 1.41), and the NNT was 100.
The per protocol analysis also showed no significant differ ence between the groups (attributable risk reduction 0.012, 95% CI -0.020 to 0.044; NNT 84). In the sensitivity analysis, there was no significant difference whether all 7 patients lost to followup were assumed to have infection or no infection (Table 2) .
About onethird (20/57 [35.1%]) of the infections were photo graphed and rated by an independent outcome assessor, with agreement for all 20 of these cases.
Adverse reactions
One episode of ocular irritation was reported in the alcoholic chlorhexidine arm, and 3 episodes of contact dermatitis were reported in the aqueous chlorhexidine arm (combined adverse effects, p = 0.6; contact dermatitis, p = 0.2). No other adverse reac tions attributable to the antiseptic preparations were reported.
Microbiologic testing of infected wounds
The results of microbiologic testing were reported for 7 (0.8%) of the patients (5 in the intervention group, 2 in the control group). All samples grew Staphylococcus aureus, and 1 sample from the alcoholic chlorhexidine arm additionally grew Pseudomonas aeruginosa. Sensitivity testing for 2 of the samples showed pan sensitive S. aureus.
Interpretation
No statistically or clinically significant differences were found between alcoholic and aqueous chlorhexidine for the preven tion of surgical site infection after minor skin excisions in gen eral practice.
These findings are consistent with previous studies of both clean surgery (i.e., gastrointestinal, genitourinary or respiratory tract not entered) and other classifications of surgical contami nation (Table 3) , which have mostly shown a trend favouring alcoholbased skin antisepsis, but no significant differences. 6, [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] In our study, there was a low incidence of contact dermatitis, and no significant difference between groups, consistent with sim ilarly low incidences (0% to 0.8%) reported in the literature. 6, 29, 34 Staphylococcus aureus was the primary organism cultured from wound swabs, again consistent with previous studies.
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Limitations
In this trial, we addressed a question that is relevant to clinicians and readily translated into clinical practice. Few large RCTs are conducted in primary care because of practical and funding diffi culties. 38, 39 However, it is important that clinical guidelines used in general practice be informed by primary care evidence, so that they will be directly applicable to patients who present to the general practitioner. 40 The study had some limitations. The baseline infection rate was lower than we predicted on the basis of previous studies. [7] [8] [9] [10] Our sample size calculation was based on a 5% absolute reduc tion in surgical site infection (from a 10% baseline rate) being clinically relevant. It is possible that general practitioners might have reconsidered the margin for superiority if the baseline rate were 7%. The observed difference might be considered clinically relevant to a clinician working in a setting with a lower baseline infection rate. [41] [42] [43] Although the gold standard, the diagnosis of surgical site infection as per CDC criteria, is subjective and prone to inter and intraobserver variability, 44 we could not blind personnel to the intervention. Furthermore, it was not financially or practically Intention-to-treat analysis n = 458
Intention-to-treat analysis n = 451
Per protocol analysis n = 441
Per protocol analysis n = 452
Protocol violations n = 10
• Commenced antibiotics for indication other than SSI n = 6 • Antiseptic ointment or preparation applied to wound n = 3 • Further sutures required because of postoperative bleeding n = 1
Protocol violations n = 6
• Commenced antibiotics for indication other than SSI n = 5 • Antiseptic ointment or preparation applied to wound n = 1 Note: COPD = chronic obstructive pulmonary disease, SD = standard deviation. *Except where indicated otherwise. †Comorbid conditions were diabetes mellitus, peripheral vascular disease, ischemic heart disease, cancer and inflammatory skin disease. ‡Medications were steroids (oral or inhaled), anticoagulants, antiplatelet agents, opioids (oral or cutaneous) and other immunosuppressive medications. §Cancerous precursors were actinic keratoses and dysplastic nevi.
feasible for a single outcome assessor to assess each wound at the 4 geographically dispersed practices. 21 An independent out come assessor rated photographs of some infections to increase the specificity (but not the sensitivity) of diagnosis; however, only 37.5% of infections were photographed. Only 7 infected wounds were sampled for bacterial culture, and for only 2 of these was antibiotic sensitivity reported; therefore, data were insufficient to draw conclusions about antibiotic resistance.
Many factors influence surgical site infection, and some poten tially important variables were inadequately recorded, such as the patient's occupation and skin integrity. Also, medical history is subject to recall bias. Other potential confounders, such as the doctor's surgical skill, could not be measured or recorded.
We did not adjust for the possible effect of clustering by gen eral practitioner or by practice; however, in previous similar trials, 7, 9 ,10,15 these factors did not produce a large design effect. Had we adjusted for a potential clustering effect, the estimated variances would likely have been larger, and the nonsignificant results would have been emphasized.
The Cochrane definition of intention to treat is the analysis of all patients who underwent randomization, regardless of whether the protocol was violated or the patients were lost to followup. 45 If data were imputed, on the basis of baseline infec tion rates, it is likely that the 7 patients lost to followup would be classified as being without infection. Our intentiontotreat analysis is presented as an availablecase analysis (including patients with protocol violations but not those lost to followup). Our sensitivity analysis is, in effect, a data imputation, in accor dance with the Cochrane definition.
The populations of Mackay and Mareeba differ slightly from the general Australian population. 19, 20 The incidence of surgical site infection in our tropical setting was higher than that for cohorts in other areas, but the relative efficacy of aqueous and alcoholic chlorhexidine is unlikely to change with climate. Our results are consistent with those of trials comparing alcoholic with aqueous preparations in clean general surgery, 25, 30, 31, 33, 35 and the results may be generalizable to this setting, as well as to other simple general practice procedures, such as insertion of a contraceptive device. No. of infections 29 35 Incidence of infection, % 6.4 7.6 0.012 (-0.021 to 0.045) NNT 84 (NNH 47 to infinity to NNT 22) 0.84 (0.52 to 1.36) Note: ARR = attributable risk reduction, CI = confidence interval, NNH = number needed to harm, NNT = number needed to treat, RR = relative risk. *Where the 95% CI of the risk difference overlaps zero, the corresponding 95% CI of the NNT includes infinity and therefore is expressed as a range from NNH (harm) to infinity to NNT (benefit). Note: ARR = absolute risk reduction, CHG = chlorhexidine, CI = confidence interval, NA = not available, NS = no statistically significant difference between intervention and control (p value not reported), PVI = povidone iodine, RR = relative risk. *"Clean" = noncontaminated wound; "clean contaminated" = operative wound in respiratory, alimentary or genitourinary tract, or minor break in aseptic technique; "contaminated" = open, fresh, accidental wound, acute nonpurulent inflammation, gross spillage from gastrointestinal tract or major break in aseptic technique. 37 †Data supplemented by analyses performed in systematic review of literature by Maiwald and colleagues. 2 ‡Data supplemented by analyses performed in systematic review of literature by Dumville and colleagues. 1 §Data from this group were excluded from analysis because of use of incise drape as an additional intervention.
